Kyle Bauser
Stock Analyst at Roth Capital
(3.41)
# 957
Out of 5,049 analysts
22
Total ratings
52.94%
Success rate
22.51%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kyle Bauser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STXS Stereotaxis | Reinstates: Buy | $4 | $2.81 | +42.60% | 1 | Nov 5, 2025 | |
| LMAT LeMaitre Vascular | Reinstates: Buy | $108 | $87.01 | +24.13% | 1 | Nov 5, 2025 | |
| ELMD Electromed | Maintains: Buy | $29 → $35 | $25.00 | +40.00% | 4 | Aug 27, 2025 | |
| SNWV SANUWAVE Health | Maintains: Buy | $54 → $55 | $27.32 | +101.32% | 2 | Aug 22, 2025 | |
| VREX Varex Imaging | Maintains: Buy | $12 → $16 | $11.83 | +35.25% | 3 | Aug 8, 2025 | |
| TCMD Tactile Systems Technology | Maintains: Neutral | $12 → $13 | $22.80 | -42.98% | 2 | Aug 5, 2025 | |
| INFU InfuSystem Holdings | Initiates: Buy | $12 | $10.35 | +15.94% | 1 | Jul 22, 2025 | |
| TECH Bio-Techne | Initiates: Buy | $65 | $59.48 | +9.28% | 1 | Jul 9, 2025 | |
| SPOK Spok Holdings | Initiates: Neutral | $15 | $13.63 | +10.05% | 2 | Sep 26, 2024 | |
| OBIO Orchestra BioMed Holdings | Initiates: Buy | $15 | $3.86 | +288.60% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $17 | $3.17 | +436.28% | 2 | Jul 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $227.88 | - | 2 | Jun 22, 2022 |
Stereotaxis
Nov 5, 2025
Reinstates: Buy
Price Target: $4
Current: $2.81
Upside: +42.60%
LeMaitre Vascular
Nov 5, 2025
Reinstates: Buy
Price Target: $108
Current: $87.01
Upside: +24.13%
Electromed
Aug 27, 2025
Maintains: Buy
Price Target: $29 → $35
Current: $25.00
Upside: +40.00%
SANUWAVE Health
Aug 22, 2025
Maintains: Buy
Price Target: $54 → $55
Current: $27.32
Upside: +101.32%
Varex Imaging
Aug 8, 2025
Maintains: Buy
Price Target: $12 → $16
Current: $11.83
Upside: +35.25%
Tactile Systems Technology
Aug 5, 2025
Maintains: Neutral
Price Target: $12 → $13
Current: $22.80
Upside: -42.98%
InfuSystem Holdings
Jul 22, 2025
Initiates: Buy
Price Target: $12
Current: $10.35
Upside: +15.94%
Bio-Techne
Jul 9, 2025
Initiates: Buy
Price Target: $65
Current: $59.48
Upside: +9.28%
Spok Holdings
Sep 26, 2024
Initiates: Neutral
Price Target: $15
Current: $13.63
Upside: +10.05%
Orchestra BioMed Holdings
Jul 25, 2024
Initiates: Buy
Price Target: $15
Current: $3.86
Upside: +288.60%
Jul 19, 2022
Maintains: Buy
Price Target: $14 → $17
Current: $3.17
Upside: +436.28%
Jun 22, 2022
Initiates: Buy
Price Target: n/a
Current: $227.88
Upside: -